Venture Partners VI Lp Sanderling serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Venture Partners VI Lp Sanderling has executed 40 insider transactions totaling $13.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2024 involved purchasing 144,676 shares valued at $535.3K.
Venture Partners VI Lp Sanderling currently holds 727,433 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners VI Lp Sanderling has been a net seller of PCRX stock. They have purchased $2.8M and sold $10.4M worth of shares.
Venture Partners VI Lp Sanderling's most recent insider trade was on Jan 23, 2024, when they purchased 144,676 shares at $3.70 per share.
Get notified when new Form 4 filings are submitted
| $3.70 |
| Discretionary |
| Jan 23, 2024 | CALC | $719.5K | Purchase | 194,472 | $3.70 | Discretionary |
| Jan 23, 2024 | CALC | $188.8K | Purchase | 51,032 | $3.70 | Discretionary |
| Jan 23, 2024 | CALC | $48.8K | Purchase | 13,184 | $3.70 | Discretionary |
| Jan 23, 2024 | CALC | $14.5K | Purchase | 3,920 | $3.70 | Discretionary |
| Jan 23, 2024 | CALC | $106.4K | Purchase | 28,744 | $3.70 | Discretionary |
| Mar 15, 2013 | PCRX | $0 | Other | 1,000,000 | $N/A | Discretionary |
| Mar 15, 2013 | PCRX | $0 | Other | 200,000 | $N/A | Discretionary |
| Mar 11, 2013 | PCRX | $9.7M | Sale | 348,951 | $27.86 | Discretionary |
| Mar 7, 2013 | PCRX | $11.3K | Exercise | 843 | $13.44 | Discretionary |
| Mar 7, 2013 | PCRX | $48.0K | Sale | 1,852 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $2.0K | Sale | 78 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $1.7K | Sale | 66 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $48.4K | Sale | 1,866 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $48.0K | Exercise | 17,839 | $2.69 | Discretionary |
| Mar 7, 2013 | PCRX | $2.0K | Exercise | 750 | $2.69 | Discretionary |
| Mar 7, 2013 | PCRX | $1.7K | Exercise | 629 | $2.69 | Discretionary |
| Mar 7, 2013 | PCRX | $48.3K | Exercise | 17,973 | $2.69 | Discretionary |
| Mar 7, 2013 | PCRX | $269.7K | Sale | 10,407 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $11.4K | Sale | 438 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $9.5K | Sale | 368 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $271.8K | Sale | 10,485 | $25.92 | Discretionary |
| Mar 7, 2013 | PCRX | $269.7K | Exercise | 20,069 | $13.44 | Discretionary |
| Mar 7, 2013 | PCRX | $271.8K | Exercise | 20,220 | $13.44 | Discretionary |
| Mar 7, 2013 | PCRX | $9.5K | Exercise | 708 | $13.44 | Discretionary |
| Feb 8, 2011 | PCRX | $0 | Conversion | 4,533 | $N/A | Discretionary |
| Feb 8, 2011 | PCRX | $0 | Conversion | 14,366 | $N/A | Discretionary |
| Feb 8, 2011 | PCRX | $0 | Conversion | 129,445 | $N/A | Discretionary |
| Feb 8, 2011 | PCRX | $0 | Conversion | 5,400 | $N/A | Discretionary |